K131605 is an FDA 510(k) clearance for the ELECSYS PRECICONTROL CMV IGG, ELECSYS CMV IGG IMMUNOASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus (Class II - Special Controls, product code LFZ).
Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on February 28, 2014, 270 days after receiving the submission on June 3, 2013.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3175.
| 510(k) Number | K131605 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 03, 2013 |
| Decision Date | February 28, 2014 |
| Days to Decision | 270 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LFZ — Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.3175 |